نتایج جستجو برای: hbv vaccine

تعداد نتایج: 121073  

Journal: :iranian journal of basic medical sciences 0
faezeh ghasemi department of new sciences and technology, faculty of medicine, mashhad university of medical sciences, mashhad, iran sina rostami the influenza centre, department of clinical science, university of bergen, n-5021 bergen, norway majid ghayour-mobarhan biochemistry of nutrition research center; school of medicine, mashhad university of medical sciences, mashhad, iran zahra meshkat antimicrobial resistance research center, faculty of medicine, mashhad university of medical sciences, mashhad, iran

chronic hepatitis b is still a major public health issue despite the successful prophylactic vaccination attempts. chronicity of hepatitis b virus(hbv) is mainly due to its ability to debilitate host's immune system. therefore, major measures have been taken to stop this process and help patients with chronic hepatitis b infection recover from their illness. while satisfactory results have...

Journal: :New biotechnology 2009
Romuald Patient Christophe Hourioux Pascal Vaudin Jean-Christophe Pagès Philippe Roingeard

The hepatitis B virus (HBV) envelope protein (S) self-assembles into subviral particles used as commercial vaccines against hepatitis B. These particles are excellent carriers for foreign epitopes, which can be inserted into the external hydrophilic loop or at the N- or C-terminal end of the HBV S protein. We show here that the N-terminal transmembrane domain (TMD) of HBV S can be replaced by t...

Journal: :novelty in biomedicine 0
mohammad hossein khosravi students' research committee, and baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, iran middle east liver diseases center (meld), tehran, iran heidar sharafi middle east liver diseases center (meld), and baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, iran seyed moayed alavian middle east liver diseases center (meld), and baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, iran

we read with a great interest the article written by davoodbeglou and colleagues entitled “evaluation of hepatitis b infection prevalence in institutionalized intellectually disabled children” which is recently published in your prestigious journal 1 . the authors concluded that hbv infection is more prevalent among institutionalized disabled children and that we should change our health polici...

Journal: :hepatitis monthly 0
reza rezaee ministry of health and medical education, deputy of curative affairs, budget administration, tehran, ir iran bahman aghcheli hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, ir iran vahdat poortahmasebi hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, ir iran mostafa qorbani department of community medicine, alborz university of medical sciences, karaj, ir iran; non-communicable disease research center, endocrinology and metabolism population sciences institute, tehran university of medical sciences, tehran, ir iran seyed moayed alavian middle east liver diseases center (meld center), tehran, ir iran seyed mohammad jazayeri hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, ir iran; hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, p. o. box: 15155-6446, tehran, ir iran. tel: +98-2188992660

context hepatitis b virus expanded program on immunization (epi) started on 1993 in iran. most surveys have assessed the level of response to vaccine by measuring the titers of anti-hbs. this meta- analysis aimed to summarize the iranian published data on the rate of vaccine-responders versus non-responders. moreover, the impact of variables such as age, gender, type of vaccine, etc. on the lev...

Journal: :Memorias do Instituto Oswaldo Cruz 2011
Ana Luiza N Junqueira Viviane R Tavares Regina M B Martins Kamilla V Frauzino Agabo M da Costa e Silva Izolina M X Rodrigues Ruth Minamisava Sheila A Teles

Recently, it was suggested that maternal hepatitis B surface antigen antibodies (anti-HBs) acquired transplacentally could play a negative role in newborn infants' immune response to the hepatitis B vaccine. We compared the hepatitis B virus (HBV) vaccine response in infants born to mothers previously vaccinated against HBV (n = 91) to infants born to mothers who were not previously vaccinated ...

Journal: :Central European journal of public health 2005
J Beran P Dedek V Stepánová M Spliio O Pozler

Patients with autoimmune hepatitis (AIH) are a group at risk of disease exacerbation or relapse of the underlying disease should they fall ill with infectious hepatitis A (HAV) or B (HBV). Therefore, it seems appropriate to protect this group of persons against HAV and HBV disease by vaccination. An open study evaluated the safety, reactogenicity and immunogenicity of a combined HAV and HBV vac...

2014
Thomas H. King Charles B. Kemmler Zhimin Guo Derrick Mann Yingnian Lu Claire Coeshott Adam J. Gehring Antonio Bertoletti Zi Z. Ho William Delaney Anuj Gaggar G. Mani Subramanian John G. McHutchison Shikha Shrivastava Yu-Jin L. Lee Shyamasundaran Kottilil Donald Bellgrau Timothy Rodell David Apelian

Chronic hepatitis B infection (CHB) is characterized by sub-optimal T cell responses to viral antigens. A therapeutic vaccine capable of restoring these immune responses could potentially improve HBsAg seroconversion rates in the setting of direct acting antiviral therapies. A yeast-based immunotherapy (Tarmogen) platform was used to make a vaccine candidate expressing hepatitis B virus (HBV) X...

2011
Emeka B. Kesieme Kenechi Uwakwe Eshiobo Irekpita Andrew Dongo Kefas John Bwala Bamidele J. Alegbeleye

Background. Hepatitis B virus (HBV) infection is a well recognised occupational health hazard preventable by vaccination. Objectives. To determine the knowledge of operating room personnel (ORP) in Nigeria about the Hepatitis B vaccine, their perception of Hepatitis B vaccination and vaccination status against HBV. Methods. Four university hospitals were selected by simple random sampling. A st...

Journal: :Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 2017
Tarcila Maria Bonfim Ferreira Tácio Giordano Santana Guimarães Andrea Martins Melo Fontenele Natalino Salgado Adalgisa de Souza Paiva Ferreira Alessandra Porto de Macedo Costa

INTRODUCTION Vaccination is the most effective tool in preventing transmission of Hepatitis B Virus (HBV). The patient with chronic kidney disease (CKD) on dialysis appear to be at greater risk of becoming infected with this virus and does not show the same vaccine response when compared to patients without uremia. OBJECTIVES To evaluate the results related to the HBV vaccine and identify fac...

Journal: :The New England journal of medicine 1984
S D Kreider W R Lange

Many Vaccine Information Statements are available in Spanish and other languages. See www.immunize.org/vis. 1 What is hepatitis B? Hepatitis B is a serious disease that affects the liver. It is caused by the hepatitis B virus (HBV). HBV can cause: Acute (short-term) illness. This can lead to: • loss of appetite • diarrhea and vomiting • tiredness • jaundice (yellow skin or eyes) • pain in muscl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید